
ISMP Newsroom
ISMP
Media Inquiries
For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.
Press Coverage

Safety of Anesthetic and Perioperative Medication Practices
This article appeared on the Pharmacy Practice News website on September 15, 2023.
En savoir plusPress Coverage

12 Hospital Departments Ranked by Supply Shortages
This article appeared on the Becker’s Hospital Review website on September 8, 2023.
En savoir plusPress Coverage

Picking Up a Prescription? 6 Tips to Avoid Dangerous Pharmacy Errors
This article appeared on the LA Times website on September 5, 2023.
En savoir plusPress Coverage

Price Gouging of Cancer Drugs in Short Supply Hits Some Hospitals Hard
This article appeared on the MSN website on August 17, 2023.
En savoir plusPress Coverage

Drug Name Confusion: More than 80 New Drug Pairs Added to List
This article appeared on the Medscape website on August 8, 2023.
En savoir plusPress Coverage

Drug Shortages Come with Many Implications for Health Systems
This article appeared on the Healthcare Brew website on August 7, 2023.
En savoir plusStay Connected
Get medication safety news, event invitations and updates straight to your inbox!
Social Media
View the Latest from ECRI

HANYS Marketplace® has partnered with ECRI, a nonprofit organization advancing the safety and quality of healthcare, to provide New York’s hospitals and health systems with evidence-based solutions...
En savoir plus
ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award
Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...
En savoir plus
ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides
The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...
En savoir plus